
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| LOCOID | Bausch Health Companies | N-018514 RX | 1982-03-31 | 1 products, RLD, RS |
| LOCOID | Bausch Health Companies | N-019116 RX | 1987-02-25 | 1 products, RLD, RS |
| LOCOID LIPOCREAM | Precision Dermatology | N-020769 RX | 1997-09-08 | 1 products, RLD, RS |
| LOCOID | Precision Dermatology | N-018652 RX | 1982-10-29 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
|---|---|---|
| aquax-h | unapproved drug other | 2024-12-31 |
| hydrocortisone butyrate | ANDA | 2025-10-06 |
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Hydrocortisone Butyrate, Locoid, Bausch | |||
| 7981877 | 2025-01-23 | DP | |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 26 | 42 | 19 | 3 | 4 | 79 |
| Adrenal insufficiency | D000309 | — | — | 6 | 6 | 11 | 20 | 35 | 76 |
| Leukemia | D007938 | — | C95 | 24 | 35 | 14 | 2 | 4 | 66 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | 7 | 6 | — | 3 | 42 | 56 |
| Septic shock | D012772 | — | A48.3 | 1 | 11 | 18 | 9 | 17 | 51 |
| Depression | D003863 | — | F33.9 | 7 | 5 | 2 | 2 | 39 | 51 |
| Cushing syndrome | D003480 | EFO_0003099 | E24 | 2 | 11 | 5 | 1 | 28 | 46 |
| Sepsis | D018805 | EFO_0001420 | A41.9 | 1 | 6 | 14 | 10 | 17 | 45 |
| Healthy volunteers/patients | — | — | — | 12 | 4 | 1 | 8 | 20 | 44 |
| Pituitary acth hypersecretion | D047748 | EFO_1001110 | E24.0 | — | 8 | 7 | 1 | 25 | 41 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Prostatic neoplasms | D011471 | — | C61 | 5 | 13 | 7 | — | 5 | 28 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 15 | 10 | 3 | — | — | 25 |
| Physiological stress | D013312 | — | — | — | — | 1 | — | 19 | 20 |
| Covid-19 | D000086382 | — | U07.1 | — | — | 7 | — | 12 | 19 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 7 | 11 | 2 | — | 2 | 19 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 4 | 3 | — | 14 | 19 |
| Hyperaldosteronism | D006929 | — | E26 | — | — | 1 | — | 17 | 18 |
| Neoplasms | D009369 | — | C80 | 3 | 7 | 1 | — | 6 | 15 |
| Burkitt lymphoma | D002051 | — | C83.7 | 1 | 8 | 6 | — | — | 14 |
| Alcoholism | D000437 | EFO_0003829 | F10.1 | 4 | 1 | 1 | — | 9 | 14 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Motor activity | D009043 | EFO_0003940 | — | — | 1 | — | — | 19 | 20 |
| Recurrence | D012008 | — | — | 9 | 8 | — | — | 3 | 14 |
| Stress fractures | D015775 | — | M84.3 | 1 | 1 | — | — | 12 | 14 |
| Adrenal gland neoplasms | D000310 | EFO_0003850 | C74 | — | 1 | — | — | 10 | 11 |
| Opioid-related disorders | D009293 | EFO_0005611 | F11 | 1 | 4 | — | — | 5 | 9 |
| Hematologic neoplasms | D019337 | — | — | 4 | 4 | — | — | 1 | 8 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | 1 | 2 | — | — | 5 | 8 |
| Adrenocortical carcinoma | D018268 | — | — | 1 | 3 | — | — | 3 | 7 |
| Anorexia nervosa | D000856 | EFO_0004215 | F50.0 | — | 1 | — | — | 6 | 7 |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | 1 | — | — | 6 | 7 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Substance-related disorders | D019966 | EFO_0003890 | F13 | 1 | — | — | — | 8 | 9 |
| Overweight | D050177 | — | E66.3 | 1 | — | — | — | 7 | 8 |
| Blood pressure | D001794 | EFO_0004325 | — | 2 | — | — | — | 3 | 5 |
| Caregiver burden | D000084802 | — | — | 1 | — | — | — | 4 | 5 |
| Chronic pain | D059350 | — | — | 1 | — | — | — | 4 | 5 |
| Cocaine-related disorders | D019970 | — | F14 | 1 | — | — | — | 4 | 5 |
| Sleep deprivation | D012892 | — | F51.12 | 2 | — | — | — | 2 | 4 |
| Fibromyalgia | D005356 | EFO_0005687 | M79.1 | 1 | — | — | — | 3 | 4 |
| Agnosia | D000377 | EFO_0007136 | F88 | 1 | — | — | — | 3 | 4 |
| Alcohol drinking | D000428 | EFO_0004329 | — | 1 | — | — | — | 3 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dental anxiety | D016854 | — | — | — | — | — | — | 10 | 10 |
| Psychological distress | D000079225 | — | — | — | — | — | — | 8 | 8 |
| Dental implants | D015921 | — | — | — | — | — | — | 8 | 8 |
| Psychological burnout | D000077062 | — | Z73.0 | — | — | — | — | 7 | 7 |
| Nursing care | D009732 | — | — | — | — | — | — | 6 | 6 |
| Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | — | — | — | 6 | 6 |
| Infertility | D007246 | EFO_0000545 | — | — | — | — | — | 5 | 5 |
| Breast feeding | D001942 | — | — | — | — | — | — | 5 | 5 |
| Low back pain | D017116 | — | M54.5 | — | — | — | — | 5 | 5 |
| Occupational stress | D000073397 | — | — | — | — | — | — | 5 | 5 |
| Drug common name | Hydrocortisone butyrate |
| INN | hydrocortisone |
| Description | Cortisol 17-butyrate is cortisol esterified with butyric acid at the 17-hydroxy group. It has a role as a dermatologic drug and a drug allergen. It is a cortisol ester, a butyrate ester and a primary alpha-hydroxy ketone. |
| Classification | Small molecule |
| Drug class | cortisone derivatives |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C |
| PDB | — |
| CAS-ID | 13609-67-1 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1683 |
| ChEBI ID | 31674 |
| PubChem CID | — |
| DrugBank | DB00741 |
| UNII ID | WI4X0X7BPJ (ChemIDplus, GSRS) |

